FuturaGene PLC / FuturaGene, Inc.
June 05

FuturaGene reports maiden full year 2004 results following to the AIM market in London

May 05

FuturaGene licence for Osmotin offers possible breakthrough treatments for obesity, heart disease and diabetes

January 05

FuturaGene graduates from Purdue Research Park


May 04

Gene firm pioneers desert crops
.

Founded in 2001, FuturaGene Inc. is a subsidiary of FuturaGene PLC (LSE:FGN), a company traded publicly on the Alternative Investment Market (AIM) of the London Stock Exchange. In 2004, FuturaGene received a Small Business Innovation Research (SBIR) Phase I award in the amount of $80,000 to develop tomatoes with enhanced salt tolerance. The company has headquarters at Purdue Research Park, which was named the top research park in the nation by its peers at the Association of University Research Parks.

www.futuragene.com

Copyright © SeedQuest - All rights reserved